Biocon added 1.36% to Rs 325.25 after the company announced that its subsidiary, Biocon Biologics (BBL), has launched YESINTEK (ustekinumab-kfce) in the United States.

After enduring years of misdiagnoses, I finally discovered that the persistent swelling, pain and disproportionate fat ...

Yale researchers have found clues as to why certain people experience adverse health effects after the COVID-19 vaccine, ...

The immune system is your body’s defense system. Although many foods and other natural options can boost immunity, find out which may be the best.

While Pope Francis' life is not in immediate danger, the level of multiple infections in his lungs means he is not completely ...

New research reveals 57% of U.S. adults regularly consume foods that fuel inflammation, increasing risks of chronic diseases.

Zing Health plans to beef up its value-base care, or VBC, business for members with chronic cardiac care needs through an ...

America’s chronic disease crisis—a problem Secretary Kennedy and the Make America Healthy Again (MAHA) brigade, armed with ...

A headache lasting more than 72 hours must be addressed in the emergency room or with a doctor. Here's why it happens and the ...

An international team of researchers has explored how multi-omics—the integration of molecular data across different ...

A recent study examines social and psychological factors that can positively affect chronic health conditions and inflammation.

As we enter 2025, the confluence of scientific advancement, market opportunity and industry validation suggests women's ...